Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene expression panel for prognosis of prostate cancer recurrence

Gene expression panel for prognosis of prostate cancer recurrence

US Patent 11098372 · Granted Aug 24, 2021

Estimated economic value: $605,584,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the amplification of nucleic acids2025
Methods and compositions for single cell genomics2025
Fluid applicator cap2023
Multiplex PCR method for the detection of SARS-CoV-22023
Car t-cell therapy directed to LHR for the treatment of solid tumors2021
Nucleic acid sequence analysis from single cells2021
Compositions and methods for the amplification of nucleic acids2020
Multiplex nucleic acid reactions2020
Methods and compositions for single cell genomics2020
Gene expression panel for prognosis of prostate cancer recurrence2019
Gene expression panel for prognosis of prostate cancer recurrence2019
Gene expression panel for prognosis of prostate cancer recurrence2019